Similar articles for PMID: 26864352

Year	Number of Results
2003	2
2004	4
2005	1
2006	1
2007	2
2009	1
2010	5
2011	3
2012	5
2013	18
2014	17
2015	23
2016	36
2017	33
2018	50
2019	50
2020	35
2021	59
2022	35
2023	16
2024	0

1

Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.

Potkin SG, Preda A. Potkin SG, et al. Expert Opin Pharmacother. 2016;17(3):395-407. doi: 10.1517/14656566.2015.1114100. Expert Opin Pharmacother. 2016. PMID: 26864352 Review.

2

Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.

Biagi E, Capuzzi E, Colmegna F, Mascarini A, Brambilla G, Ornaghi A, Santambrogio J, Clerici M. Biagi E, et al. Adv Ther. 2017 May;34(5):1036-1048. doi: 10.1007/s12325-017-0507-x. Epub 2017 Apr 5. Adv Ther. 2017. PMID: 28382557 Free PMC article. Review.

3

Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.

Tempest M, Sapin C, Beillat M, Robinson P, Treur M. Tempest M, et al. J Ment Health Policy Econ. 2015 Dec;18(4):185-200. J Ment Health Policy Econ. 2015. PMID: 26729007

4

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder.

Harlin M, Yildirim M, Such P, Madera-McDonough J, Jan M, Jin N, Watkin S, Larsen F. Harlin M, et al. CNS Drugs. 2023 Apr;37(4):337-350. doi: 10.1007/s40263-023-00996-8. Epub 2023 Mar 24. CNS Drugs. 2023. PMID: 36961650 Free PMC article. Clinical Trial.

5

Initiation of aripiprazole once-monthly in patients with schizophrenia.

Raoufinia A, Baker RA, Eramo A, Nylander AG, Landsberg W, Kostic D, Larsen F. Raoufinia A, et al. Curr Med Res Opin. 2015 Mar;31(3):583-92. doi: 10.1185/03007995.2015.1006356. Epub 2015 Feb 5. Curr Med Res Opin. 2015. PMID: 25586294 Review.

6

Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder.

Hebbrecht K, Morrens M, Neels H, Roosens L, Sabbe BGC. Hebbrecht K, et al. Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):999-1005. doi: 10.1080/17425255.2018.1515911. Epub 2018 Sep 7. Expert Opin Drug Metab Toxicol. 2018. PMID: 30141352 Review.

7

Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies.

Cameron C, Zummo J, Desai D, Drake C, Hutton B, Kotb A, Weiden PJ. Cameron C, et al. Curr Med Res Opin. 2018 Apr;34(4):725-733. doi: 10.1080/03007995.2017.1410471. Epub 2018 Jan 10. Curr Med Res Opin. 2018. PMID: 29179595

8

Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.

Swainston Harrison T, Perry CM. Swainston Harrison T, et al. Drugs. 2004;64(15):1715-36. doi: 10.2165/00003495-200464150-00010. Drugs. 2004. PMID: 15257633 Review.

9

Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents.

Aggarwal A, Gopalakrishna G, Lauriello J. Aggarwal A, et al. Clin Schizophr Relat Psychoses. 2016 spring;10(1):58-63. doi: 10.3371/csrp.AGGA.040316. Clin Schizophr Relat Psychoses. 2016. PMID: 27074333 Review.

10

Aripiprazole Lauroxil: A Review in Schizophrenia.

Frampton JE. Frampton JE. Drugs. 2017 Dec;77(18):2049-2056. doi: 10.1007/s40265-017-0848-4. Drugs. 2017. PMID: 29177572 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

345 results

Results by year